Arbutus Biopharma ABUS Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	204.49M	236.88M	215.84M	203.8M	195.42M	191.22M	176.82M	158.64M
Total Current Assets	160.66M	172.7M	157.79M	141.14M	151.14M	152.85M	158.8M	141.61M
Cash and Equivalents	109.28M	81.33M	47.32M	24M	30.78M	40.57M	27.2M	17.53M
Total Non-Current Assets	47.72M	67.84M	61.62M	66.09M	47.61M	41.56M	21.81M	22.07M
Total Liabilities	35.05M	71.03M	62.69M	58.28M	58.57M	47.31M	42.13M	39.3M
Total Current Liabilities	11.22M	32.41M	29.82M	27.51M	32.86M	25.15M	24.53M	22.32M
Total Non-Current Liabilities	26.06M	40.72M	34.96M	32.73M	27.53M	23.83M	19.25M	16.98M
Common Equity	1.29B	1.3B	1.3B	1.31B	1.32B	1.34B	1.34B	1.35B
Retained Earnings	-1.13B	-1.15B	-1.16B	-1.18B	-1.2B	-1.22B	-1.24B	-1.26B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	275.92M	237.16M	227.91M	105.54M	137.08M	204.49M	195.42M	144.4M
Total Current Assets	132.56M	129.37M	129.23M	93.83M	127.7M	160.66M	151.14M	132.03M
Cash and Equivalents	23.41M	54.29M	36.94M	31.8M	52.25M	109.28M	30.78M	26.29M
Total Non-Current Assets	203.01M	182.47M	200.23M	72.74M	101.97M	169.44M	136.85M	106.02M
Total Liabilities	72.91M	54.69M	27.67M	32.79M	35.11M	35.05M	58.57M	38.38M
Total Current Liabilities	10.59M	14.63M	11.24M	7.83M	9.54M	11.22M	32.86M	22.49M
Total Non-Current Liabilities	74.33M	52.06M	16.43M	27.98M	28.17M	26.06M	27.53M	15.9M
Total Equity	203.01M	182.47M	200.23M	72.74M	101.97M	169.44M	136.85M	106.02M
Common Equity	867.39M	925.89M	1.01B	1.04B	1.14B	1.29B	1.32B	1.35B
Retained Earnings	-651.15M	-738.07M	-805.22M	-970.09M	-1.05B	-1.13B	-1.2B	-1.28B